thiocolchicine
![]() |
- ₹5650.65 - ₹23176.33
- Product name: thiocolchicine
- CAS: 2730-71-4
- MF: C22H25NO5S
- MW: 415.5
- EINECS:220-346-8
- MDL Number:MFCD01736965
- Synonyms:thiocolchicine;thiocholchicine;(S)-7-Acetylamino-6,7-dihydro-10-methylthio-1,2,3-trimethoxybenzo[a]heptalen-9(5H)-one;(S)-7α-Acetylamino-6,7-dihydro-10-(methylthio)-1,2,3-trimethoxybenzo[a]heptalene-9(5H)-one;10-Demethoxy-10-methylthiocolchicine;10-Thiocolchicine;N-[(S)-5,6,7,9-Tetrahydro-1,2,3-trimethoxy-10-methylthio-9-oxobenzo[a]heptalen-7-yl]acetamide;N-[(7S)-5,6,7,9-Tetrahydro-1,2,3-triMethoxy-10-(Methylthio)-9-oxobenzo[a]heptalen-7-yl]acetaMide
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 5MG
- 25MG
- ManufacturerSigma-Aldrich(India)
- Product numberSML0954
- Product descriptionThiocolchicine ≥97% (HPLC)
- Packaging5MG
- Price₹5650.65
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberSML0954
- Product descriptionThiocolchicine ≥97% (HPLC)
- Packaging25MG
- Price₹23176.33
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML0954 | Thiocolchicine ≥97% (HPLC) | 5MG | ₹5650.65 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML0954 | Thiocolchicine ≥97% (HPLC) | 25MG | ₹23176.33 | 2022-06-14 | Buy |
Properties
Melting point :193℃
alpha :D20 -221°
Boiling point :729.1±60.0 °C(Predicted)
Density :1.27±0.1 g/cm3(Predicted)
storage temp. :-20°C
solubility :DMSO: soluble10mg/mL, clear
form :powder
pka :14.75±0.40(Predicted)
color :white to beige
alpha :D20 -221°
Boiling point :729.1±60.0 °C(Predicted)
Density :1.27±0.1 g/cm3(Predicted)
storage temp. :-20°C
solubility :DMSO: soluble10mg/mL, clear
form :powder
pka :14.75±0.40(Predicted)
color :white to beige
Safety Information
Symbol(GHS): |
![]() ![]() ![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||
Precautionary statements: |
|